(124) demonstrated that tumor tissues from patients with ccRCC who responded favorably to ICIs exhibited significantly higher CD8+ T cell infiltration and PD-L1 positivity compared to non-responders. The gene discussed is CD8A; the disease is nonpapillary renal cell carcinoma.